Additionally, dihydrotanshinone I increased the number of 53BP1 foci in a dose-dependent manner, with dihydrotanshinone I at 5.0 μM reaching ∼4 53BP1 foci per nucleus in HCC cells (Figs. 2C, 2D). This evidence concerns the gene TP53BP1 and hepatocellular carcinoma.